TRANSIENT SUPPRESSION OF XPO1 ACTIVITY IS SUFFICIENT FOR SELINEXOR-INDUCED CYTOTOXICITY IN GLIOBLASTOMA CELLS LINES.

被引：0
|
作者：
Tang, Yongjian [1 ]
Sprinzen, Lisa [1 ]
Terada, Yukinori [1 ]
Pieper, Russell [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DDDR-04
引用
收藏
页数：1
相关论文
共 3 条
  • [1] E3 ubiquitin ligase ASB8 promotes selinexor-induced proteasomal degradation of XPO1
    Kwanten, Bert
    Deconick, Tine
    Walker, Christopher
    Wang, Feng
    Landesman, Yosef
    Daelemans, Dirk
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 160
  • [2] The XPO1 Inhibitor Selinexor Inhibits Translation and Enhances the Radiosensitivity of Glioblastoma Cells Grown In Vitro and In Vivo
    Wahba, Amy
    Rath, Barbara H.
    O'Neill, John W.
    Camphausen, Kevin
    Tofilon, Philip J.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (08) : 1717 - 1726
  • [3] Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells
    Etchin, Julia
    Le, Bonnie Thi
    Berezovskaya, Alla
    Conway, Amy S.
    Chen, Weihsu C.
    Kentsis, Alex
    Mansour, Marc R.
    Stone, Richard M.
    Galinsky, Ilene A.
    DeAngelo, Daniel J.
    McCauley, Dilara
    Kauffman, Michael
    Shacham, Sharon
    Wang, Jean C. Y.
    Kung, Andrew L.
    Look, Thomas
    CANCER RESEARCH, 2015, 75
1